| FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
| |||||||||||||||
| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | |||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
| 2. Issuer Name and Ticker or Trading Symbol CIMARRON SOFTWARE INC [ CRSO ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
| ||||||||||||||||||||||||
| 3. Date of Earliest Transaction (Month/Day/Year) 11/21/1996 | ||||||||||||||||||||||||||
| 4. If Amendment, Date of Original Filed (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||||||||||||
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Class A | 11/21/1996 | J(1) | 120 | D | $0(1) | 0(1) | D | |||
| Common | 11/21/1996 | J(1) | 214,286 | A | $0(1) | 214,286(1) | D(1) | |||
| Common | 02/08/2001 | J(2) | 120,000 | D | $0(2) | 94,286(2) | D(2) | |||
| Common | 02/08/2001 | J(2) | 120,000 | A | $0(2) | 120,000(2) | I(2) | By Rare Principle, L.C. | ||
| Common | 05/10/2002 | S(3) | 18,813 | D | $13.54(3) | 75,473(3) | D(3) | |||
| Common | 05/10/2002 | S(3) | 23,943 | D | $13.54(3) | 96,057(3) | I(3) | By Rare Principle, L.C. | ||
| Common | 03/31/2005 | A(4) | 120,000 | A | $0.01(4) | 195,473(4) | D(4) | |||
| Common | 06/01/2008 | J(5) | 195,473 | D | $0(5) | 0(5) | D(5) | |||
| Common | 06/01/2008 | J(5) | 195,473 | A | $0(5) | 291,530(5) | I(5) | By Rare Principle, L.C. | ||
| Series A Preferred Stock | 03/16/2015 | P(4) | 100,059.95 | A | $0.1(6) | 100,059.5(6) | I(6) | By Rare Principle, L.C. | ||
| Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Explanation of Responses: |
| 1. Class A shares converted to Common Stock. |
| 2. Mr. Sargent transferred 120,000 shares of Common Stock held in his name into the name of Rare Principle, L.C., retaining 94,286 shares of Common Stock held in his name. Mr. Sargent has sole voting and dispositive power with respect to the shares held in the name of Rare Principle, L.C., and is therefore deemed the beneficial owner of the shares held in its name. |
| 3. Mr. Sargent sold 18,813 shares of Common Stock to Amersham Biosciences, and Rare Principle, L.C. sold 23,943 shares of Common Stock to Amersham Biosciences, as part of Amersham Bioscience's partial acquisition of the issuer. |
| 4. 120,000 shares of Common Stock were issued to Mr. Sargent pursuant to Mr. Sargent's exercise of employee stock options. |
| 5. Mr. Sargent transferred all 195,473 shares of Common Stock held in his name into the name of Rare Principle, L.C. |
| 6. 100,059.5 shares of Series A Preferred Stock acquired from preferred stockholders for $0.10/share. |
| /s/ Robert John Sargent | 05/15/2015 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
